Please assess the completion status of the following clinical trial:

Trial Title: Defining the Utility of PET/CT in the Follow-up of Patients With Solid Tumors

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Completed primary therapy such that no disease is evident at the time of enrollment in the study~Exclusion Criteria:~* Patients unable to consent~* Without diagnosis of colorectal cancer~* Non-small cell lung cancer or squamous cell cancer of the head and neck~* Unwilling or unable to participate in the assigned follow-up program~* Having a serum glucose at time of PET/CT greater than 180mg/dl~* Stage IV disease or with evidence of disease recurrence post treatment~* Who are not a candidate for further treatment should a recurrence of disease be identified

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- PET/CT follow-up (Type: ACTIVE_COMPARATOR): PET/CT with history and physical exams at 3,9,18,36,60 months only
- conventional follow-up (Type: OTHER): NCCN recommendations

Based on this trial design, predict the completion outcome and termination type (if applicable).